GABRG3 and diabetes mellitus: GABRG3-rs2192224, rs2499511, LOC105379144-rs12719264 were replicated in the UKB cohort, showing consistent effects with previous results [26,32], demonstrating their potential as biomarkers for albuminuria in individuals with diabetes.